These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 21460795)

  • 1. Secreted factors from brain endothelial cells maintain glioblastoma stem-like cell expansion through the mTOR pathway.
    Galan-Moya EM; Le Guelte A; Lima Fernandes E; Thirant C; Dwyer J; Bidere N; Couraud PO; Scott MG; Junier MP; Chneiweiss H; Gavard J
    EMBO Rep; 2011 May; 12(5):470-6. PubMed ID: 21460795
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of PI3K-Akt-mTOR signaling in glioblastoma by mTORC1/2 inhibitors.
    Fan QW; Weiss WA
    Methods Mol Biol; 2012; 821():349-59. PubMed ID: 22125077
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Akt and autophagy cooperate to promote survival of drug-resistant glioma.
    Fan QW; Cheng C; Hackett C; Feldman M; Houseman BT; Nicolaides T; Haas-Kogan D; James CD; Oakes SA; Debnath J; Shokat KM; Weiss WA
    Sci Signal; 2010 Nov; 3(147):ra81. PubMed ID: 21062993
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Defining the role of mTOR pathway in the regulation of stem cells of glioblastoma.
    Jhanwar-Uniyal M; Gellerson O; Bree J; Das M; Kleinman G; Gandhi CD
    Adv Biol Regul; 2023 May; 88():100946. PubMed ID: 36658088
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dual targeting of AKT and mammalian target of rapamycin: a potential therapeutic approach for malignant peripheral nerve sheath tumor.
    Zou CY; Smith KD; Zhu QS; Liu J; McCutcheon IE; Slopis JM; Meric-Bernstam F; Peng Z; Bornmann WG; Mills GB; Lazar AJ; Pollock RE; Lev D
    Mol Cancer Ther; 2009 May; 8(5):1157-68. PubMed ID: 19417153
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endothelial Cell mTOR Complex-2 Regulates Sprouting Angiogenesis.
    Farhan MA; Carmine-Simmen K; Lewis JD; Moore RB; Murray AG
    PLoS One; 2015; 10(8):e0135245. PubMed ID: 26295809
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The mTOR/AP-1/VEGF signaling pathway regulates vascular endothelial cell growth.
    Wang S; Lu J; You Q; Huang H; Chen Y; Liu K
    Oncotarget; 2016 Aug; 7(33):53269-53276. PubMed ID: 27458160
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of epidermal growth factor receptor and phosphatase and tensin homologue gene expression on the inhibition of U87MG glioblastoma cell proliferation induced by protein kinase inhibitors.
    Xing WJ; Zou Y; Han QL; Dong YC; Deng ZL; Lv XH; Jiang T; Ren H
    Clin Exp Pharmacol Physiol; 2013 Jan; 40(1):13-21. PubMed ID: 23110505
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dual inhibition of PI3Kalpha and mTOR as an alternative treatment for Kaposi's sarcoma.
    Chaisuparat R; Hu J; Jham BC; Knight ZA; Shokat KM; Montaner S
    Cancer Res; 2008 Oct; 68(20):8361-8. PubMed ID: 18922908
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dual blocking of mTor and PI3K elicits a prodifferentiation effect on glioblastoma stem-like cells.
    Sunayama J; Sato A; Matsuda K; Tachibana K; Suzuki K; Narita Y; Shibui S; Sakurada K; Kayama T; Tomiyama A; Kitanaka C
    Neuro Oncol; 2010 Dec; 12(12):1205-19. PubMed ID: 20861085
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of chemokine (CXC motif) ligand 12/chemokine (CXC motif) receptor 4 axis (CXCL12/CXCR4)-mediated cell migration by targeting mammalian target of rapamycin (mTOR) pathway in human gastric carcinoma cells.
    Chen G; Chen SM; Wang X; Ding XF; Ding J; Meng LH
    J Biol Chem; 2012 Apr; 287(15):12132-41. PubMed ID: 22337890
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rapamycin-mediated mTOR inhibition attenuates survivin and sensitizes glioblastoma cells to radiation therapy.
    Anandharaj A; Cinghu S; Park WY
    Acta Biochim Biophys Sin (Shanghai); 2011 Apr; 43(4):292-300. PubMed ID: 21367753
    [TBL] [Abstract][Full Text] [Related]  

  • 13. GSK3 is required for rapalogs to induce degradation of some oncogenic proteins and to suppress cancer cell growth.
    Koo J; Wang X; Owonikoko TK; Ramalingam SS; Khuri FR; Sun SY
    Oncotarget; 2015 Apr; 6(11):8974-87. PubMed ID: 25797247
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A molecular cascade modulates MAP1B and confers resistance to mTOR inhibition in human glioblastoma.
    Laks DR; Oses-Prieto JA; Alvarado AG; Nakashima J; Chand S; Azzam DB; Gholkar AA; Sperry J; Ludwig K; Condro MC; Nazarian S; Cardenas A; Shih MYS; Damoiseaux R; France B; Orozco N; Visnyei K; Crisman TJ; Gao F; Torres JZ; Coppola G; Burlingame AL; Kornblum HI
    Neuro Oncol; 2018 May; 20(6):764-775. PubMed ID: 29136244
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rapamycin inhibits the proliferation of endothelial cells in hemangioma by blocking the mTOR-FABP4 pathway.
    Wang Y; Chen J; Tang W; Zhang Y; Li X
    Biomed Pharmacother; 2017 Jan; 85():272-279. PubMed ID: 27914823
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mammalian target of rapamycin signaling inhibition ameliorates vascular calcification via Klotho upregulation.
    Zhao Y; Zhao MM; Cai Y; Zheng MF; Sun WL; Zhang SY; Kong W; Gu J; Wang X; Xu MJ
    Kidney Int; 2015 Oct; 88(4):711-21. PubMed ID: 26061549
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TBK1 regulates prostate cancer dormancy through mTOR inhibition.
    Kim JK; Jung Y; Wang J; Joseph J; Mishra A; Hill EE; Krebsbach PH; Pienta KJ; Shiozawa Y; Taichman RS
    Neoplasia; 2013 Sep; 15(9):1064-74. PubMed ID: 24027431
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic and pharmacologic evidence that mTOR targeting outweighs mTORC1 inhibition as an antimyeloma strategy.
    Chen X; Díaz-Rodríguez E; Ocio EM; Paiva B; Mortensen DS; Lopez-Girona A; Chopra R; Miguel JS; Pandiella A
    Mol Cancer Ther; 2014 Feb; 13(2):504-16. PubMed ID: 24431075
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A dual PI3K/mTOR inhibitor, PI-103, cooperates with stem cell-delivered TRAIL in experimental glioma models.
    Bagci-Onder T; Wakimoto H; Anderegg M; Cameron C; Shah K
    Cancer Res; 2011 Jan; 71(1):154-63. PubMed ID: 21084267
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rapamycin antagonizes TNF induction of VCAM-1 on endothelial cells by inhibiting mTORC2.
    Wang C; Qin L; Manes TD; Kirkiles-Smith NC; Tellides G; Pober JS
    J Exp Med; 2014 Mar; 211(3):395-404. PubMed ID: 24516119
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.